Moreover, EGFR mutations in NSCLC have immunosuppressive effects, and previous studies have reported that the EGFR mutations can modulate several factors to impact TME, such as TILs, Tregs, MDSCs, TAMs, and immunoregulatory cytokines (80, 81). This evidence concerns the gene EGFR and non-small cell lung carcinoma.